Combretastatin-Chalcone Hybrids: Synthesis and Cytotoxicity

Author(s): Nguyen-Hai Nam, Ahn Byung-Zun.

Journal Name: Medicinal Chemistry

Volume 3 , Issue 4 , 2007

Become EABM
Become Reviewer

Abstract:

A series of all-trans-1-aryl-4-aryl-5-aryl-2,4-pentanediene-1-one (3), a hybridized form of chalcone and combretastatin, was synthesized and evaluated against a panel of cancer cell lines, including B16, murine melanoma; HCT116, colon cancer; A431, human epidermoid carcinoma; and human umbilical venous endothelial cells (HUVEC). Structure-activity relationships analysis of this series revealed that a 2,5-dihydroxyphenyl at position 1 of the 2,4- pentanediene-1-one was essential for cytotoxicity. all-trans-1-(2,5-Dihydroxyphenyl)-5-(4-methoxyphenyl)-4-(3,4,5- trimethoxyphenyl)-2,4-pentanediene-1-one (3a) was the most potent compound from this series.

Keywords: Combretastatin, chalcone, synthesis, cytotoxicity

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 3
ISSUE: 4
Year: 2007
Page: [373 - 377]
Pages: 5
DOI: 10.2174/157340607781024366
Price: $58

Article Metrics

PDF: 4